ABSTRACT
Differentiation of neural lineages from human pluripotent stem cells (hPSCs) raises the hope of generating functional cells for the treatment of neural diseases. However, current protocols for differentiating hPSCs into neural lineages remain inefficient and largely variable between different hPSC lines. We report that microRNA 376c (miR-376c) significantly enhanced neural differentiation of hPSCs in a defined condition by suppressing SMAD4, the co-SMAD for TGF-ß signaling. Downstream, SMAD4 directly bound and suppressed PAX6, the critical neural lineage specification factor. Interestingly, we also found that SMAD4 binds and suppresses miR-376c clusters in undifferentiated hESCs. In summary, our findings revealed a reciprocal antagonism between miR-376c and SMAD signaling that regulates cell fate during human neural differentiation.
Subject(s)
Cell Differentiation , MicroRNAs/metabolism , Pluripotent Stem Cells/cytology , Signal Transduction , Smad4 Protein/metabolism , Transforming Growth Factor beta/metabolism , Cell Differentiation/physiology , Cells, Cultured , Gene Knockdown Techniques/methods , Humans , Pluripotent Stem Cells/metabolism , Signal Transduction/physiologyABSTRACT
BACKGROUND: Cell-to-cell interactions are complex processes that involve physical interactions, chemical binding, and biological signaling pathways. Identification of the functions of special signaling pathway in cell-to-cell interaction from the very first contact will help characterize the mechanism underlying the interaction and advance new drug discovery. METHODS: This paper reported a case study of characterizing initial interaction between leukemia cancer cells and bone marrow stromal cells, through the use of an optical tweezers-based cell manipulation tool. Optical traps were used to assemble leukemia cells at different positions of the stromal cell layer and enable their interactions by applying a small trapping force to maintain the cell contact for a few minutes. Specific drug was used to inhibit the binding of molecules during receptor-ligand-mediated adhesion. RESULTS AND CONCLUSIONS: Our results showed that the amount of adhesion molecule could affect cell adhesion during the first few minutes contact. We also found that leukemia cancer cells could migrate on the stromal cell layer, which was dependent on the adhesion state and activation triggered by specific chemokine. The reported approaches provided a new opportunity to investigate cell-to-cell interaction through single cell adhesion manipulation.
Subject(s)
Cell Adhesion/physiology , Cell Communication/physiology , Leukemia, Myeloid, Acute/physiopathology , Mesenchymal Stem Cells/physiology , Micromanipulation/instrumentation , Optical Tweezers , Cell Line , Cell Separation/instrumentation , Cell Separation/methods , Equipment Design , Equipment Failure Analysis , Humans , Leukemia, Myeloid, Acute/pathology , Mesenchymal Stem Cells/cytology , Micromanipulation/methods , Stress, MechanicalABSTRACT
Mesenchymal stromal/stem cells (MSCs) are easily obtained multipotent cells that are widely applied in regenerative medicine. Electrical stimulation (ES) has a promoting effect on bone healing and osteogenic differentiation of MSCs. Direct and alternating currents (AC) are extensively used to promote the osteogenic differentiation of MSCs in vivo and in vitro. However, information on conducting effective differentiation remains scarce. In this paper, we propose a method to optimize ES parameters based on calcium spike patterns of MSCs. Calcium spike frequency decreases as the osteogenic differentiation of MSC progresses. Furthermore, we tested various ES parameters through the real-time monitoring of calcium spike patterns. We efficiently initiated the process of osteogenic differentiation in MSCs by using the optimal parameters of AC, including voltage, signal shapes, frequency, and duty time. This method provides a new approach to optimize osteogenic differentiation and is potentially useful in clinical treatment such as of bone fractures.
Subject(s)
Calcium Signaling/physiology , Calcium , Electric Stimulation , Mesenchymal Stem Cells , Osteogenesis/physiology , Calcium/metabolism , Calcium/physiology , Cells, Cultured , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiologyABSTRACT
Single cell surgery such as manipulation or removal of subcellular components or/and organelles from single cells is increasingly used for the study of diseases and their causes in precision medicine. This paper presents a robotic surgery system to achieve automated organelle biopsy of single cells with dimensions of less than 20 µm in diameter. The complexity of spatial detection of the organelle position is reduced by patterning the cells using a microfluidic chip device. A sliding mode nonlinear controller is developed to enable extraction of organelles, such as the mitochondria and the nucleus, from single cells with high precision. An image processing algorithm is also developed to automatically detect the position of the desired organelle. The effectiveness of the proposed robotic surgery system is demonstrated experimentally with automated extraction of mitochondria and nucleus from human acute promyelocytic leukemia cells and human fibroblast cells. Extraction is followed by biological tests to indicate the functionality of biopsied mitochondria as well as the cell viability after removal of mitochondria. The results presented here have revealed that the proposed approach of automated organelle biopsy on single small cells is feasible.
Subject(s)
Image Processing, Computer-Assisted/methods , Microfluidic Analytical Techniques/methods , Micromanipulation/methods , Single-Cell Analysis/methods , Algorithms , Cell Line, Tumor , Cells, Cultured , Equipment Design , Humans , Microfluidic Analytical Techniques/instrumentation , Micromanipulation/instrumentation , Mitochondria/physiology , Robotic Surgical Procedures , Single-Cell Analysis/instrumentationABSTRACT
One of the greatest challenges in acute myeloid leukemia (AML) treatment is preventing relapse. Leukemia cells can hide in bone marrow niche or vascular niche. Hence, many chemical drugs cannot kill these cells. To characterize migration and adhesion properties of leukemia cells in specific niches, CXCR4/SDF- 1α signal pathway has been widely used for investigation. AMD3100 is treated as one of the most common chemical drugs that can inhibit this signal. In the current study, we particularly investigate the effect of AMD3100 on the adhesion property of leukemia cells on stromal cells by using engineering tools, namely, optical tweezers (OT) and dielectrophoresis (DEP), to probe single cell property. AMD3100 not only inhibits the CXCR4/SDF- 1α signal pathway but also reduces gene expression of CXCR4 and VLA-4 on leukemia cells. The drug also softens leukemia cells. This work provides a new way to investigate cell behavior under drug treatment. The use of combined engineering tools will benefit drug discovery and assessment for leukemia treatment.
Subject(s)
Antineoplastic Agents/pharmacology , Electrophoresis/methods , Heterocyclic Compounds/pharmacology , Leukemia, Myeloid, Acute/metabolism , Optical Tweezers , Single-Cell Analysis/methods , Benzylamines , Cell Adhesion/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Chemokine CXCL12/analysis , Chemokine CXCL12/genetics , Chemokine CXCL12/metabolism , Coculture Techniques , Cyclams , Humans , Receptors, CXCR4/analysis , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Signal Transduction/drug effects , Stromal Cells/cytology , Stromal Cells/drug effectsABSTRACT
Generation of induced pluripotent stem cells (iPSCs) from human urine-derived cells (hUCs) provides a convenient and non-invasive way to obtain patient-specific iPSCs. However, many isolated hUCs exhibit very poor proliferation and are difficult to reprogram. In this study, we optimized reprogramming approaches for hUCs with very poor proliferation. We report here that a compound cocktail containing cyclic pifithrin-a (a P53 inhibitor), A-83-01, CHIR99021, thiazovivin, NaB, and PD0325901 significantly improves the reprogramming efficiency (170-fold more) for hUCs. In addition, we showed that replacement of Matrigel with autologous hUC feeders can overcome the reprogramming failure due to the massive cell death that occurs during delivery of reprogramming factors. In summary, we describe improved approaches to enable iPSC generation from hUCs that were otherwise difficult to reprogram, a valuable asset for banking patient-specific iPSCs.
Subject(s)
Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cellular Reprogramming/drug effects , Induced Pluripotent Stem Cells/drug effects , Benzamides/pharmacology , Benzothiazoles/pharmacology , Diphenylamine/analogs & derivatives , Diphenylamine/pharmacology , Humans , Induced Pluripotent Stem Cells/cytology , Pyrazoles/pharmacology , Pyridines/pharmacology , Pyrimidines/pharmacology , Thiazoles/pharmacology , Thiosemicarbazones/pharmacology , Toluene/analogs & derivatives , Toluene/pharmacology , Urine/cytologyABSTRACT
Induced pluripotent stem cell (iPS cell) holds great potential for applications in regenerative medicine, drug discovery, and disease modeling. We describe here a practical method to generate human iPS cells from urine-derived cells (UCs) under feeder-free, virus-free, serum-free condition and without oncogene c-MYC. We showed that this approach could be applied in a large population with different genetic backgrounds. UCs are easily accessible and exhibit high reprogramming efficiency, offering advantages over other cell types used for the purpose of iPS generation. Using the approach described in this study, we have generated 93 iPS cell lines from 20 donors with diverse genetic backgrounds. The non-viral iPS cell bank with these cell lines provides a valuable resource for iPS cells research, facilitating future applications of human iPS cells.